tiprankstipranks
Advertisement

ISMD - ETF AI Analysis

Compare

Top Page

ISMD

Inspire Small/Mid Cap Impact ETF (ISMD)

Rating:64Neutral
Price Target:
ISMD, the Inspire Small/Mid Cap Impact ETF, earns a solid overall rating thanks to several financially strong and strategically well-positioned holdings like Blackbaud and Karat Packaging, which show healthy revenue trends, supportive earnings calls, and appealing valuations or dividends. However, weaker names such as Pulse Biosciences and Embecta, both facing ongoing losses or revenue declines and leverage issues, weigh on the fund’s quality. The main risk factor is the ETF’s exposure to multiple companies with profitability and bearish technical challenges, which can increase volatility even as the stronger holdings help support the fund’s long-term potential.
Positive Factors
Strong Recent Performance
The ETF has shown strong gains so far this year and over the last few months, indicating solid recent momentum.
Broad Sector Diversification
Holdings are spread across many sectors like industrials, financials, technology, consumer, health care, and real estate, which helps reduce the impact of weakness in any single industry.
Healthy Asset Size
The fund manages a sizable pool of assets, which can support better liquidity and stability compared with very small niche ETFs.
Negative Factors
Higher-Than-Average Fees
The expense ratio is on the higher side for an ETF, which means more of your returns go toward fees instead of staying in your pocket.
Mixed Performance Among Top Holdings
Several of the largest positions have weak or lagging performance, which can drag on the fund even though some holdings are doing well.
Heavy U.S. Exposure
Almost all of the ETF’s investments are in U.S. companies, offering little geographic diversification if the U.S. market faces a downturn.

ISMD vs. SPDR S&P 500 ETF (SPY)

ISMD Summary

ISMD is the Inspire Small/Mid Cap Impact ETF, which follows the Inspire Small/Mid Cap Impact Equal Weight Index and focuses on smaller U.S. companies with strong ethical and moral standards. It invests across many sectors, including industrials, technology, and financials, and holds names like UTZ Brands and Amplitude. Someone might invest in ISMD to seek growth from small and mid-sized companies while staying aligned with faith-based or values-driven investing. A key risk is that smaller company stocks can be more volatile, so the ETF’s price can go up and down more sharply than the overall market.
How much will it cost me?The Inspire Small/Mid Cap Impact ETF (ISMD) has an expense ratio of 0.57%, which means you’ll pay $5.70 per year for every $1,000 invested. This is higher than average for ETFs because it is actively managed and focuses on ethical investing, which involves more research and selection processes. While the cost is higher, it reflects the fund's commitment to aligning investments with specific moral and ethical standards.
What would affect this ETF?The Inspire Small/Mid Cap Impact ETF (ISMD) could benefit from growth in innovative sectors like technology and health care, as well as increased interest in ethical investing. However, it may face challenges from economic slowdowns that disproportionately affect small and mid-cap companies, as well as potential regulatory changes impacting industries like energy and financials. Its focus on U.S.-based firms also makes it sensitive to domestic economic conditions and interest rate fluctuations.

ISMD Top 10 Holdings

ISMD is powered by a diverse cast of U.S. small and mid-caps, with health care and tech names like Xencor, Varex Imaging, and Amplitude doing much of the heavy lifting as their shares have been rising on growth and innovation stories. Consumer-focused holdings such as UTZ Brands and The Honest Company add a steady, brand-driven flavor to the mix. On the flip side, companies like Pulse Biosciences and TaskUs are more mixed, with financial and technical headwinds that can drag on returns. Overall, the fund spreads its bets across sectors rather than leaning on a single star.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Amplitude0.39%$1.32M$1.79B25.11%
52
Neutral
UTZ Brands0.37%$1.27M$2.04B5.81%
56
Neutral
TaskUs0.37%$1.26M$769.25M-52.11%
62
Neutral
Varex Imaging0.36%$1.24M$779.74M60.17%
50
Neutral
JELD-WEN0.35%$1.19M$219.51M-60.41%
40
Underperform
CBIZ0.34%$1.16M$2.96B-15.54%
66
Neutral
Pulse Biosciences0.34%$1.16M$3.39B206.11%
44
Neutral
Blackbaud0.33%$1.13M$2.21B-27.12%
70
Outperform
Xencor0.32%$1.10M$1.94B220.54%
59
Neutral
Embecta Corporation0.31%$1.07M$286.13M-65.12%
52
Neutral

ISMD Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
49.45
Negative
100DMA
47.62
Positive
200DMA
43.86
Positive
Market Momentum
MACD
-0.20
Positive
RSI
47.67
Neutral
STOCH
48.19
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ISMD, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 49.48, equal to the 50-day MA of 49.45, and equal to the 200-day MA of 43.86, indicating a neutral trend. The MACD of -0.20 indicates Positive momentum. The RSI at 47.67 is Neutral, neither overbought nor oversold. The STOCH value of 48.19 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ISMD.

ISMD Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$335.82M0.53%
64
Neutral
$780.73M0.75%
68
Neutral
$724.68M0.62%
64
Neutral
$528.44M0.75%
70
Outperform
$331.41M0.49%
68
Neutral
$279.04M0.55%
68
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ISMD
Inspire Small/Mid Cap Impact ETF
49.06
10.54
27.36%
RSMC
Rockefeller U.S. Small-Mid Cap ETF
MSSM
Morgan Stanley Pathway Small-Mid Cap Equity ETF
GRNJ
Fundstrat Granny Shots US Small- & Mid-Cap ETF
SMOT
VanEck Morningstar SMID Moat ETF
SMIZ
Zacks Small/Mid Cap ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement